18 and older, any sex, with Health Insurance or Childhood Cancer Survivors. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Acceptability of the Health Insurance Navigation ProgramPrimary· 5 month follow-up
10-point (1-10; 1= least helpful and 10= most helpful) scale rating of program quality, including the following (higher scores indicate higher levels of acceptability)-
* program materials
* scheduling
* communication with navigator
* length and number of sessions (investigator created scale)
Group
Value
95% CI
Navigation Intervention
8.9
± 1.2
Percentage of Participants Completing All 4 Intervention SessionsPrimary· 1-2 months follow-up
Program feasibility is measured by the percentage of participants completing all 4 intervention sessions.
Group
Value
95% CI
Navigation Intervention
33
Change From Baseline Familiarity With ACA Provisions to 5-month Follow-upSecondary· baseline and 5 month follow-up
6 items rating familiarity with key Affordable Care Act (ACA) protections (scores range from 0-6; higher scores indicate higher degree of familiarity) (scale adapted from CCSS Health Insurance Survey)
Group
Value
95% CI
Navigation Intervention
1.7
± 1.7
Enhanced Usual Care
0.5
± 1.6
Change From Baseline Health Insurance Literacy to 5-month Follow-upSecondary· baseline and 5 month follow-up
16 items with a 4-category Likert scale ranging from 16-64 (higher scores denoting lower literacy) of confidence on understanding of health insurance terms (higher scores indicate higher levels of health insurance literacy). We report mean health insurance literacy change from baseline to follow-up. Scale adapted from the Urban Institute Health Reform Monitoring Survey-
* premium
* deductible
* co-payments
* co-insurance
Group
Value
95% CI
Navigation Intervention
9.1
± 7.6
Enhanced Usual Care
1.8
± 7.9
Sponsor's own description
Dr. Park and her colleagues published findings in the Journal of Clinical Oncology demonstrating that CCSS survivors, compared to siblings, were significantly more likely to be uninsured and to have difficulties obtaining health insurance. Given the current insurance landscape and the additional insurance burden that childhood cancer survivors face, the present study seeks to develop and pilot a health insurance navigation program targeted at feasibility and acceptability with survivors, and improving health insurance literacy and ameliorating financial distress related to medical costs. The proposed health insurance navigation will involve 4 navigator-led health insurance navigation sessions. The study investigators propose that, compared to the control arm (who will receive a health insurance information guide, but will not receive the navigation intervention), participants in the intervention arm will have improved health insurance literacy and decreased financial distress related to medical costs.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
NCT03585946 — Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
· withdrawn
NCT07214831 — A Feasibility and Acceptability Study of a Large Language Model-based Chatbot for Brief Alcohol Intervention Among Emerg
· NA
· not yet recruiting
NCT06686901 — A Randomized Controlled Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
· NA
· not yet recruiting
NCT05854212 — Behavioral Economics to Implement Nutrition Ranking in Food Pantries
· NA
· not yet recruiting
NCT07323446 — The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation
· EARLY_PHASE1
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Massachusetts General Hospital
Last refreshed: 3 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04520061.